# Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

> **NCT07297940** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DA-1229_01
- **DRUG:** DA-1229_01-R

## Key facts

- **NCT ID:** NCT07297940
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-14
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07297940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07297940, "Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07297940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*